nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—AOX1—Methotrexate—multiple sclerosis	0.086	0.382	CbGbCtD
Zonisamide—CYP3A4—Fingolimod—multiple sclerosis	0.0259	0.115	CbGbCtD
Zonisamide—CYP2C19—Prednisone—multiple sclerosis	0.0209	0.0928	CbGbCtD
Zonisamide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0167	0.0741	CbGbCtD
Zonisamide—SCN3A—spinal nerve—multiple sclerosis	0.0152	0.0585	CbGeAlD
Zonisamide—CYP2C19—Dexamethasone—multiple sclerosis	0.0131	0.0579	CbGbCtD
Zonisamide—CYP3A4—Triamcinolone—multiple sclerosis	0.0126	0.0561	CbGbCtD
Zonisamide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0122	0.054	CbGbCtD
Zonisamide—CYP3A4—Betamethasone—multiple sclerosis	0.0108	0.0482	CbGbCtD
Zonisamide—CYP3A4—Prednisolone—multiple sclerosis	0.0107	0.0475	CbGbCtD
Zonisamide—CYP3A4—Prednisone—multiple sclerosis	0.0101	0.0449	CbGbCtD
Zonisamide—CA13—nerve—multiple sclerosis	0.00925	0.0356	CbGeAlD
Zonisamide—SCN11A—peripheral nervous system—multiple sclerosis	0.00812	0.0313	CbGeAlD
Zonisamide—SCN11A—nerve—multiple sclerosis	0.00633	0.0244	CbGeAlD
Zonisamide—CYP3A4—Dexamethasone—multiple sclerosis	0.00631	0.028	CbGbCtD
Zonisamide—CA10—brainstem—multiple sclerosis	0.00473	0.0182	CbGeAlD
Zonisamide—CA8—brainstem—multiple sclerosis	0.00464	0.0179	CbGeAlD
Zonisamide—CA13—brainstem—multiple sclerosis	0.00397	0.0153	CbGeAlD
Zonisamide—SCN2B—medulla oblongata—multiple sclerosis	0.00381	0.0147	CbGeAlD
Zonisamide—SCN2B—midbrain—multiple sclerosis	0.00348	0.0134	CbGeAlD
Zonisamide—SCN2B—spinal cord—multiple sclerosis	0.00339	0.0131	CbGeAlD
Zonisamide—CA11—brainstem—multiple sclerosis	0.00333	0.0128	CbGeAlD
Zonisamide—CA10—medulla oblongata—multiple sclerosis	0.0033	0.0127	CbGeAlD
Zonisamide—CA11—retina—multiple sclerosis	0.00322	0.0124	CbGeAlD
Zonisamide—SCN3B—medulla oblongata—multiple sclerosis	0.00318	0.0122	CbGeAlD
Zonisamide—CA10—midbrain—multiple sclerosis	0.00302	0.0116	CbGeAlD
Zonisamide—CA10—spinal cord—multiple sclerosis	0.00294	0.0113	CbGeAlD
Zonisamide—SCN3B—midbrain—multiple sclerosis	0.0029	0.0112	CbGeAlD
Zonisamide—SCN2B—nervous system—multiple sclerosis	0.00286	0.011	CbGeAlD
Zonisamide—SCN3B—spinal cord—multiple sclerosis	0.00283	0.0109	CbGeAlD
Zonisamide—SCN2B—central nervous system—multiple sclerosis	0.00275	0.0106	CbGeAlD
Zonisamide—SCN4B—medulla oblongata—multiple sclerosis	0.0027	0.0104	CbGeAlD
Zonisamide—SCN2B—cerebellum—multiple sclerosis	0.00269	0.0104	CbGeAlD
Zonisamide—CA1—nerve—multiple sclerosis	0.00266	0.0102	CbGeAlD
Zonisamide—SCN1B—nervous system—multiple sclerosis	0.00259	0.00996	CbGeAlD
Zonisamide—SCN1B—central nervous system—multiple sclerosis	0.00249	0.00959	CbGeAlD
Zonisamide—CA10—nervous system—multiple sclerosis	0.00248	0.00955	CbGeAlD
Zonisamide—SCN4B—midbrain—multiple sclerosis	0.00247	0.00951	CbGeAlD
Zonisamide—SCN1B—cerebellum—multiple sclerosis	0.00243	0.00937	CbGeAlD
Zonisamide—CA8—nervous system—multiple sclerosis	0.00243	0.00936	CbGeAlD
Zonisamide—SCN4B—spinal cord—multiple sclerosis	0.00241	0.00927	CbGeAlD
Zonisamide—CA10—central nervous system—multiple sclerosis	0.00239	0.00919	CbGeAlD
Zonisamide—SCN3B—nervous system—multiple sclerosis	0.00239	0.00919	CbGeAlD
Zonisamide—CA8—central nervous system—multiple sclerosis	0.00234	0.00901	CbGeAlD
Zonisamide—CA10—cerebellum—multiple sclerosis	0.00233	0.00898	CbGeAlD
Zonisamide—CA11—medulla oblongata—multiple sclerosis	0.00233	0.00895	CbGeAlD
Zonisamide—SCN3B—central nervous system—multiple sclerosis	0.0023	0.00885	CbGeAlD
Zonisamide—CA8—cerebellum—multiple sclerosis	0.00229	0.00881	CbGeAlD
Zonisamide—SCN3B—cerebellum—multiple sclerosis	0.00225	0.00865	CbGeAlD
Zonisamide—SCN2B—brain—multiple sclerosis	0.00219	0.00842	CbGeAlD
Zonisamide—MAOB—nerve—multiple sclerosis	0.00216	0.00831	CbGeAlD
Zonisamide—CA11—midbrain—multiple sclerosis	0.00213	0.00818	CbGeAlD
Zonisamide—CA13—nervous system—multiple sclerosis	0.00208	0.00801	CbGeAlD
Zonisamide—CA4—nerve—multiple sclerosis	0.00208	0.008	CbGeAlD
Zonisamide—CA11—spinal cord—multiple sclerosis	0.00207	0.00798	CbGeAlD
Zonisamide—SCN4B—nervous system—multiple sclerosis	0.00203	0.00781	CbGeAlD
Zonisamide—CA13—central nervous system—multiple sclerosis	0.002	0.00771	CbGeAlD
Zonisamide—SCN1B—brain—multiple sclerosis	0.00198	0.00761	CbGeAlD
Zonisamide—CA13—cerebellum—multiple sclerosis	0.00196	0.00754	CbGeAlD
Zonisamide—SCN4B—central nervous system—multiple sclerosis	0.00195	0.00752	CbGeAlD
Zonisamide—SCN4B—cerebellum—multiple sclerosis	0.00191	0.00735	CbGeAlD
Zonisamide—CA10—brain—multiple sclerosis	0.0019	0.0073	CbGeAlD
Zonisamide—CACNA1I—cerebellum—multiple sclerosis	0.00187	0.00718	CbGeAlD
Zonisamide—CA8—brain—multiple sclerosis	0.00186	0.00716	CbGeAlD
Zonisamide—MAOA—nerve—multiple sclerosis	0.00184	0.00709	CbGeAlD
Zonisamide—SCN3B—brain—multiple sclerosis	0.00182	0.00702	CbGeAlD
Zonisamide—CA11—nervous system—multiple sclerosis	0.00175	0.00673	CbGeAlD
Zonisamide—SCN11A—spinal cord—multiple sclerosis	0.00169	0.00651	CbGeAlD
Zonisamide—CA11—central nervous system—multiple sclerosis	0.00168	0.00648	CbGeAlD
Zonisamide—CA11—cerebellum—multiple sclerosis	0.00164	0.00633	CbGeAlD
Zonisamide—CA13—brain—multiple sclerosis	0.00159	0.00612	CbGeAlD
Zonisamide—SCN1A—brainstem—multiple sclerosis	0.00156	0.006	CbGeAlD
Zonisamide—SCN4B—brain—multiple sclerosis	0.00155	0.00597	CbGeAlD
Zonisamide—CACNA1I—brain—multiple sclerosis	0.00152	0.00583	CbGeAlD
Zonisamide—SCN2A—brainstem—multiple sclerosis	0.00143	0.0055	CbGeAlD
Zonisamide—SCN11A—nervous system—multiple sclerosis	0.00142	0.00548	CbGeAlD
Zonisamide—CA7—midbrain—multiple sclerosis	0.00141	0.00544	CbGeAlD
Zonisamide—SCN11A—central nervous system—multiple sclerosis	0.00137	0.00528	CbGeAlD
Zonisamide—CACNA1G—nervous system—multiple sclerosis	0.00136	0.00523	CbGeAlD
Zonisamide—CA11—brain—multiple sclerosis	0.00134	0.00514	CbGeAlD
Zonisamide—CACNA1G—central nervous system—multiple sclerosis	0.00131	0.00504	CbGeAlD
Zonisamide—CA14—medulla oblongata—multiple sclerosis	0.00129	0.00496	CbGeAlD
Zonisamide—CACNA1G—cerebellum—multiple sclerosis	0.00128	0.00492	CbGeAlD
Zonisamide—CA14—midbrain—multiple sclerosis	0.00118	0.00453	CbGeAlD
Zonisamide—SCN9A—midbrain—multiple sclerosis	0.00115	0.00444	CbGeAlD
Zonisamide—CA14—spinal cord—multiple sclerosis	0.00115	0.00442	CbGeAlD
Zonisamide—SCN9A—spinal cord—multiple sclerosis	0.00113	0.00433	CbGeAlD
Zonisamide—CA7—cerebellum—multiple sclerosis	0.00109	0.00421	CbGeAlD
Zonisamide—SCN11A—brain—multiple sclerosis	0.00109	0.00419	CbGeAlD
Zonisamide—SCN1A—medulla oblongata—multiple sclerosis	0.00109	0.00418	CbGeAlD
Zonisamide—CA3—nervous system—multiple sclerosis	0.00107	0.0041	CbGeAlD
Zonisamide—CACNA1G—brain—multiple sclerosis	0.00104	0.004	CbGeAlD
Zonisamide—CA3—central nervous system—multiple sclerosis	0.00103	0.00395	CbGeAlD
Zonisamide—SCN2A—medulla oblongata—multiple sclerosis	0.000997	0.00384	CbGeAlD
Zonisamide—SCN1A—midbrain—multiple sclerosis	0.000993	0.00382	CbGeAlD
Zonisamide—SCN1A—spinal cord—multiple sclerosis	0.000968	0.00373	CbGeAlD
Zonisamide—CA9—cerebellum—multiple sclerosis	0.00096	0.0037	CbGeAlD
Zonisamide—MAOB—brainstem—multiple sclerosis	0.000926	0.00357	CbGeAlD
Zonisamide—CA14—cerebellum—multiple sclerosis	0.000911	0.00351	CbGeAlD
Zonisamide—SCN2A—midbrain—multiple sclerosis	0.000911	0.00351	CbGeAlD
Zonisamide—CA4—brainstem—multiple sclerosis	0.000892	0.00344	CbGeAlD
Zonisamide—CACNA1H—nervous system—multiple sclerosis	0.000889	0.00342	CbGeAlD
Zonisamide—SCN2A—spinal cord—multiple sclerosis	0.000889	0.00342	CbGeAlD
Zonisamide—CA7—brain—multiple sclerosis	0.000888	0.00342	CbGeAlD
Zonisamide—SCN3A—medulla oblongata—multiple sclerosis	0.000876	0.00337	CbGeAlD
Zonisamide—SCN4A—nervous system—multiple sclerosis	0.000846	0.00326	CbGeAlD
Zonisamide—CACNA1H—cerebellum—multiple sclerosis	0.000836	0.00322	CbGeAlD
Zonisamide—SCN1A—nervous system—multiple sclerosis	0.000816	0.00314	CbGeAlD
Zonisamide—CA3—brain—multiple sclerosis	0.000815	0.00314	CbGeAlD
Zonisamide—SCN4A—central nervous system—multiple sclerosis	0.000815	0.00314	CbGeAlD
Zonisamide—SCN3A—midbrain—multiple sclerosis	0.000801	0.00308	CbGeAlD
Zonisamide—MAOA—brainstem—multiple sclerosis	0.00079	0.00304	CbGeAlD
Zonisamide—SCN1A—central nervous system—multiple sclerosis	0.000786	0.00302	CbGeAlD
Zonisamide—SCN3A—spinal cord—multiple sclerosis	0.000781	0.00301	CbGeAlD
Zonisamide—SCN1A—cerebellum—multiple sclerosis	0.000768	0.00296	CbGeAlD
Zonisamide—MAOA—retina—multiple sclerosis	0.000763	0.00294	CbGeAlD
Zonisamide—CA12—nervous system—multiple sclerosis	0.000755	0.00291	CbGeAlD
Zonisamide—SCN2A—nervous system—multiple sclerosis	0.000749	0.00288	CbGeAlD
Zonisamide—CA14—brain—multiple sclerosis	0.00074	0.00285	CbGeAlD
Zonisamide—CA2—brainstem—multiple sclerosis	0.00074	0.00285	CbGeAlD
Zonisamide—CA12—central nervous system—multiple sclerosis	0.000727	0.0028	CbGeAlD
Zonisamide—SCN9A—brain—multiple sclerosis	0.000725	0.00279	CbGeAlD
Zonisamide—SCN2A—central nervous system—multiple sclerosis	0.000721	0.00278	CbGeAlD
Zonisamide—CA2—retina—multiple sclerosis	0.000714	0.00275	CbGeAlD
Zonisamide—CA1—spinal cord—multiple sclerosis	0.00071	0.00273	CbGeAlD
Zonisamide—SCN2A—cerebellum—multiple sclerosis	0.000705	0.00271	CbGeAlD
Zonisamide—CACNA1H—brain—multiple sclerosis	0.000679	0.00262	CbGeAlD
Zonisamide—CA5B—nervous system—multiple sclerosis	0.000677	0.00261	CbGeAlD
Zonisamide—SCN3A—nervous system—multiple sclerosis	0.000658	0.00253	CbGeAlD
Zonisamide—SCN5A—nervous system—multiple sclerosis	0.000656	0.00253	CbGeAlD
Zonisamide—CA5B—central nervous system—multiple sclerosis	0.000652	0.00251	CbGeAlD
Zonisamide—SCN4A—brain—multiple sclerosis	0.000647	0.00249	CbGeAlD
Zonisamide—MAOB—medulla oblongata—multiple sclerosis	0.000646	0.00249	CbGeAlD
Zonisamide—SCN3A—central nervous system—multiple sclerosis	0.000634	0.00244	CbGeAlD
Zonisamide—SCN5A—central nervous system—multiple sclerosis	0.000632	0.00243	CbGeAlD
Zonisamide—SCN1A—brain—multiple sclerosis	0.000624	0.0024	CbGeAlD
Zonisamide—CA4—medulla oblongata—multiple sclerosis	0.000622	0.0024	CbGeAlD
Zonisamide—SCN3A—cerebellum—multiple sclerosis	0.000619	0.00238	CbGeAlD
Zonisamide—CA1—nervous system—multiple sclerosis	0.000598	0.0023	CbGeAlD
Zonisamide—AOX1—cerebellum—multiple sclerosis	0.000593	0.00228	CbGeAlD
Zonisamide—MAOB—midbrain—multiple sclerosis	0.00059	0.00227	CbGeAlD
Zonisamide—CA12—brain—multiple sclerosis	0.000577	0.00222	CbGeAlD
Zonisamide—MAOB—spinal cord—multiple sclerosis	0.000576	0.00222	CbGeAlD
Zonisamide—CA1—central nervous system—multiple sclerosis	0.000576	0.00222	CbGeAlD
Zonisamide—SCN2A—brain—multiple sclerosis	0.000572	0.0022	CbGeAlD
Zonisamide—CA4—midbrain—multiple sclerosis	0.000569	0.00219	CbGeAlD
Zonisamide—CA4—spinal cord—multiple sclerosis	0.000555	0.00214	CbGeAlD
Zonisamide—MAOA—medulla oblongata—multiple sclerosis	0.000551	0.00212	CbGeAlD
Zonisamide—CA5B—brain—multiple sclerosis	0.000518	0.00199	CbGeAlD
Zonisamide—CA2—medulla oblongata—multiple sclerosis	0.000516	0.00199	CbGeAlD
Zonisamide—MAOA—midbrain—multiple sclerosis	0.000504	0.00194	CbGeAlD
Zonisamide—SCN3A—brain—multiple sclerosis	0.000503	0.00194	CbGeAlD
Zonisamide—SCN5A—brain—multiple sclerosis	0.000502	0.00193	CbGeAlD
Zonisamide—MAOA—spinal cord—multiple sclerosis	0.000491	0.00189	CbGeAlD
Zonisamide—MAOB—nervous system—multiple sclerosis	0.000485	0.00187	CbGeAlD
Zonisamide—AOX1—brain—multiple sclerosis	0.000481	0.00185	CbGeAlD
Zonisamide—CA2—midbrain—multiple sclerosis	0.000472	0.00182	CbGeAlD
Zonisamide—CA4—nervous system—multiple sclerosis	0.000467	0.0018	CbGeAlD
Zonisamide—MAOB—central nervous system—multiple sclerosis	0.000467	0.0018	CbGeAlD
Zonisamide—CA2—spinal cord—multiple sclerosis	0.00046	0.00177	CbGeAlD
Zonisamide—CA1—brain—multiple sclerosis	0.000457	0.00176	CbGeAlD
Zonisamide—MAOB—cerebellum—multiple sclerosis	0.000457	0.00176	CbGeAlD
Zonisamide—CA4—central nervous system—multiple sclerosis	0.00045	0.00173	CbGeAlD
Zonisamide—CA4—cerebellum—multiple sclerosis	0.00044	0.00169	CbGeAlD
Zonisamide—MAOA—nervous system—multiple sclerosis	0.000414	0.00159	CbGeAlD
Zonisamide—MAOA—central nervous system—multiple sclerosis	0.000399	0.00153	CbGeAlD
Zonisamide—MAOA—cerebellum—multiple sclerosis	0.00039	0.0015	CbGeAlD
Zonisamide—CA2—nervous system—multiple sclerosis	0.000388	0.00149	CbGeAlD
Zonisamide—CA2—central nervous system—multiple sclerosis	0.000373	0.00144	CbGeAlD
Zonisamide—MAOB—brain—multiple sclerosis	0.000371	0.00143	CbGeAlD
Zonisamide—CA2—cerebellum—multiple sclerosis	0.000365	0.0014	CbGeAlD
Zonisamide—CA4—brain—multiple sclerosis	0.000357	0.00138	CbGeAlD
Zonisamide—MAOA—brain—multiple sclerosis	0.000317	0.00122	CbGeAlD
Zonisamide—CA2—brain—multiple sclerosis	0.000296	0.00114	CbGeAlD
Zonisamide—CYP3A4—nervous system—multiple sclerosis	0.00025	0.000963	CbGeAlD
Zonisamide—CYP3A4—central nervous system—multiple sclerosis	0.000241	0.000927	CbGeAlD
Zonisamide—Vertigo—Betamethasone—multiple sclerosis	0.000226	0.000691	CcSEcCtD
Zonisamide—Vertigo—Dexamethasone—multiple sclerosis	0.000226	0.000691	CcSEcCtD
Zonisamide—Syncope—Dexamethasone—multiple sclerosis	0.000225	0.00069	CcSEcCtD
Zonisamide—Syncope—Betamethasone—multiple sclerosis	0.000225	0.00069	CcSEcCtD
Zonisamide—Infection—Triamcinolone—multiple sclerosis	0.000224	0.000688	CcSEcCtD
Zonisamide—Sweating—Methotrexate—multiple sclerosis	0.000224	0.000687	CcSEcCtD
Zonisamide—Infection—Methylprednisolone—multiple sclerosis	0.000224	0.000686	CcSEcCtD
Zonisamide—Haematuria—Methotrexate—multiple sclerosis	0.000223	0.000683	CcSEcCtD
Zonisamide—Shock—Triamcinolone—multiple sclerosis	0.000222	0.000681	CcSEcCtD
Zonisamide—Insomnia—Prednisolone—multiple sclerosis	0.000222	0.000681	CcSEcCtD
Zonisamide—Alopecia—Prednisone—multiple sclerosis	0.000222	0.00068	CcSEcCtD
Zonisamide—Shock—Methylprednisolone—multiple sclerosis	0.000222	0.00068	CcSEcCtD
Zonisamide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000221	0.000678	CcSEcCtD
Zonisamide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000221	0.000677	CcSEcCtD
Zonisamide—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000221	0.000676	CcSEcCtD
Zonisamide—Loss of consciousness—Betamethasone—multiple sclerosis	0.000221	0.000676	CcSEcCtD
Zonisamide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000221	0.000676	CcSEcCtD
Zonisamide—Paraesthesia—Prednisolone—multiple sclerosis	0.000221	0.000676	CcSEcCtD
Zonisamide—Tachycardia—Triamcinolone—multiple sclerosis	0.00022	0.000676	CcSEcCtD
Zonisamide—Mental disorder—Prednisone—multiple sclerosis	0.00022	0.000675	CcSEcCtD
Zonisamide—Nausea—Azathioprine—multiple sclerosis	0.00022	0.000674	CcSEcCtD
Zonisamide—Tachycardia—Methylprednisolone—multiple sclerosis	0.00022	0.000674	CcSEcCtD
Zonisamide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000219	0.000671	CcSEcCtD
Zonisamide—Malnutrition—Prednisone—multiple sclerosis	0.000219	0.00067	CcSEcCtD
Zonisamide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000218	0.000669	CcSEcCtD
Zonisamide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000218	0.000669	CcSEcCtD
Zonisamide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000218	0.000668	CcSEcCtD
Zonisamide—Convulsion—Betamethasone—multiple sclerosis	0.000218	0.000667	CcSEcCtD
Zonisamide—Convulsion—Dexamethasone—multiple sclerosis	0.000218	0.000667	CcSEcCtD
Zonisamide—Hypertension—Dexamethasone—multiple sclerosis	0.000217	0.000664	CcSEcCtD
Zonisamide—Hypertension—Betamethasone—multiple sclerosis	0.000217	0.000664	CcSEcCtD
Zonisamide—Asthenia—Mitoxantrone—multiple sclerosis	0.000215	0.000658	CcSEcCtD
Zonisamide—Myalgia—Dexamethasone—multiple sclerosis	0.000214	0.000655	CcSEcCtD
Zonisamide—Myalgia—Betamethasone—multiple sclerosis	0.000214	0.000655	CcSEcCtD
Zonisamide—Anxiety—Dexamethasone—multiple sclerosis	0.000213	0.000653	CcSEcCtD
Zonisamide—Anxiety—Betamethasone—multiple sclerosis	0.000213	0.000653	CcSEcCtD
Zonisamide—Discomfort—Dexamethasone—multiple sclerosis	0.000211	0.000647	CcSEcCtD
Zonisamide—Discomfort—Betamethasone—multiple sclerosis	0.000211	0.000647	CcSEcCtD
Zonisamide—Hypotension—Methylprednisolone—multiple sclerosis	0.000211	0.000645	CcSEcCtD
Zonisamide—Pharyngitis—Methotrexate—multiple sclerosis	0.000208	0.000639	CcSEcCtD
Zonisamide—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000207	0.000635	CcSEcCtD
Zonisamide—Urethral disorder—Methotrexate—multiple sclerosis	0.000206	0.000631	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000206	0.000631	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000205	0.000629	CcSEcCtD
Zonisamide—Oedema—Dexamethasone—multiple sclerosis	0.000205	0.000628	CcSEcCtD
Zonisamide—Oedema—Betamethasone—multiple sclerosis	0.000205	0.000628	CcSEcCtD
Zonisamide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000205	0.000628	CcSEcCtD
Zonisamide—Insomnia—Triamcinolone—multiple sclerosis	0.000204	0.000626	CcSEcCtD
Zonisamide—Insomnia—Methylprednisolone—multiple sclerosis	0.000204	0.000625	CcSEcCtD
Zonisamide—Infection—Dexamethasone—multiple sclerosis	0.000204	0.000624	CcSEcCtD
Zonisamide—Infection—Betamethasone—multiple sclerosis	0.000204	0.000624	CcSEcCtD
Zonisamide—Ill-defined disorder—Prednisone—multiple sclerosis	0.000203	0.000622	CcSEcCtD
Zonisamide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000203	0.000622	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000202	0.00062	CcSEcCtD
Zonisamide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000202	0.00062	CcSEcCtD
Zonisamide—Anaemia—Prednisone—multiple sclerosis	0.000202	0.000619	CcSEcCtD
Zonisamide—Shock—Dexamethasone—multiple sclerosis	0.000202	0.000618	CcSEcCtD
Zonisamide—Shock—Betamethasone—multiple sclerosis	0.000202	0.000618	CcSEcCtD
Zonisamide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000201	0.000617	CcSEcCtD
Zonisamide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000201	0.000616	CcSEcCtD
Zonisamide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000201	0.000616	CcSEcCtD
Zonisamide—Agitation—Prednisone—multiple sclerosis	0.000201	0.000616	CcSEcCtD
Zonisamide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000201	0.000615	CcSEcCtD
Zonisamide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000201	0.000615	CcSEcCtD
Zonisamide—Tachycardia—Betamethasone—multiple sclerosis	0.0002	0.000613	CcSEcCtD
Zonisamide—Tachycardia—Dexamethasone—multiple sclerosis	0.0002	0.000613	CcSEcCtD
Zonisamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000199	0.000609	CcSEcCtD
Zonisamide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000198	0.000608	CcSEcCtD
Zonisamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000198	0.000608	CcSEcCtD
Zonisamide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000198	0.000607	CcSEcCtD
Zonisamide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000198	0.000607	CcSEcCtD
Zonisamide—Malaise—Prednisone—multiple sclerosis	0.000197	0.000604	CcSEcCtD
Zonisamide—Vertigo—Prednisone—multiple sclerosis	0.000196	0.000602	CcSEcCtD
Zonisamide—Eye disorder—Methotrexate—multiple sclerosis	0.000196	0.000601	CcSEcCtD
Zonisamide—Syncope—Prednisone—multiple sclerosis	0.000196	0.000601	CcSEcCtD
Zonisamide—Tinnitus—Methotrexate—multiple sclerosis	0.000196	0.0006	CcSEcCtD
Zonisamide—Anorexia—Betamethasone—multiple sclerosis	0.000195	0.000599	CcSEcCtD
Zonisamide—Anorexia—Dexamethasone—multiple sclerosis	0.000195	0.000599	CcSEcCtD
Zonisamide—Urticaria—Prednisolone—multiple sclerosis	0.000195	0.000598	CcSEcCtD
Zonisamide—Fatigue—Triamcinolone—multiple sclerosis	0.000195	0.000597	CcSEcCtD
Zonisamide—Fatigue—Methylprednisolone—multiple sclerosis	0.000194	0.000596	CcSEcCtD
Zonisamide—Loss of consciousness—Prednisone—multiple sclerosis	0.000192	0.000589	CcSEcCtD
Zonisamide—Hypotension—Dexamethasone—multiple sclerosis	0.000191	0.000587	CcSEcCtD
Zonisamide—Hypotension—Betamethasone—multiple sclerosis	0.000191	0.000587	CcSEcCtD
Zonisamide—Vomiting—Mitoxantrone—multiple sclerosis	0.00019	0.000583	CcSEcCtD
Zonisamide—Immune system disorder—Methotrexate—multiple sclerosis	0.00019	0.000581	CcSEcCtD
Zonisamide—Convulsion—Prednisone—multiple sclerosis	0.000189	0.000581	CcSEcCtD
Zonisamide—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000189	0.00058	CcSEcCtD
Zonisamide—Hypertension—Prednisone—multiple sclerosis	0.000189	0.000579	CcSEcCtD
Zonisamide—Rash—Mitoxantrone—multiple sclerosis	0.000189	0.000579	CcSEcCtD
Zonisamide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000189	0.000578	CcSEcCtD
Zonisamide—Headache—Mitoxantrone—multiple sclerosis	0.000188	0.000575	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000187	0.000572	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000187	0.000572	CcSEcCtD
Zonisamide—Myalgia—Prednisone—multiple sclerosis	0.000186	0.000571	CcSEcCtD
Zonisamide—Arthralgia—Prednisone—multiple sclerosis	0.000186	0.000571	CcSEcCtD
Zonisamide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000186	0.00057	CcSEcCtD
Zonisamide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000186	0.000569	CcSEcCtD
Zonisamide—Anxiety—Prednisone—multiple sclerosis	0.000186	0.000569	CcSEcCtD
Zonisamide—Alopecia—Methotrexate—multiple sclerosis	0.000186	0.000569	CcSEcCtD
Zonisamide—Insomnia—Dexamethasone—multiple sclerosis	0.000185	0.000568	CcSEcCtD
Zonisamide—Insomnia—Betamethasone—multiple sclerosis	0.000185	0.000568	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000185	0.000567	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000184	0.000565	CcSEcCtD
Zonisamide—Paraesthesia—Betamethasone—multiple sclerosis	0.000184	0.000564	CcSEcCtD
Zonisamide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000184	0.000564	CcSEcCtD
Zonisamide—Discomfort—Prednisone—multiple sclerosis	0.000184	0.000564	CcSEcCtD
Zonisamide—Mental disorder—Methotrexate—multiple sclerosis	0.000184	0.000564	CcSEcCtD
Zonisamide—Malnutrition—Methotrexate—multiple sclerosis	0.000183	0.00056	CcSEcCtD
Zonisamide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000181	0.000555	CcSEcCtD
Zonisamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.00018	0.000553	CcSEcCtD
Zonisamide—Dyspepsia—Betamethasone—multiple sclerosis	0.00018	0.000553	CcSEcCtD
Zonisamide—Urticaria—Triamcinolone—multiple sclerosis	0.000179	0.00055	CcSEcCtD
Zonisamide—Urticaria—Methylprednisolone—multiple sclerosis	0.000179	0.000549	CcSEcCtD
Zonisamide—Dysgeusia—Methotrexate—multiple sclerosis	0.000179	0.000549	CcSEcCtD
Zonisamide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000179	0.000547	CcSEcCtD
Zonisamide—Oedema—Prednisone—multiple sclerosis	0.000178	0.000547	CcSEcCtD
Zonisamide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000178	0.000546	CcSEcCtD
Zonisamide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000178	0.000546	CcSEcCtD
Zonisamide—Decreased appetite—Betamethasone—multiple sclerosis	0.000178	0.000546	CcSEcCtD
Zonisamide—Nausea—Mitoxantrone—multiple sclerosis	0.000178	0.000545	CcSEcCtD
Zonisamide—Infection—Prednisone—multiple sclerosis	0.000177	0.000543	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000177	0.000542	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000177	0.000542	CcSEcCtD
Zonisamide—Fatigue—Dexamethasone—multiple sclerosis	0.000177	0.000542	CcSEcCtD
Zonisamide—Fatigue—Betamethasone—multiple sclerosis	0.000177	0.000542	CcSEcCtD
Zonisamide—Shock—Prednisone—multiple sclerosis	0.000176	0.000538	CcSEcCtD
Zonisamide—Nervous system disorder—Prednisone—multiple sclerosis	0.000175	0.000536	CcSEcCtD
Zonisamide—Tachycardia—Prednisone—multiple sclerosis	0.000174	0.000534	CcSEcCtD
Zonisamide—Skin disorder—Prednisone—multiple sclerosis	0.000173	0.000531	CcSEcCtD
Zonisamide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000173	0.000529	CcSEcCtD
Zonisamide—Anorexia—Prednisone—multiple sclerosis	0.00017	0.000521	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00017	0.00052	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—multiple sclerosis	0.000169	0.000518	CcSEcCtD
Zonisamide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000169	0.000518	CcSEcCtD
Zonisamide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000169	0.000518	CcSEcCtD
Zonisamide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000168	0.000514	CcSEcCtD
Zonisamide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000168	0.000514	CcSEcCtD
Zonisamide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000166	0.00051	CcSEcCtD
Zonisamide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000166	0.000509	CcSEcCtD
Zonisamide—Malaise—Methotrexate—multiple sclerosis	0.000165	0.000505	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—multiple sclerosis	0.000164	0.000503	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—multiple sclerosis	0.000164	0.000501	CcSEcCtD
Zonisamide—Urticaria—Dexamethasone—multiple sclerosis	0.000163	0.000499	CcSEcCtD
Zonisamide—Urticaria—Betamethasone—multiple sclerosis	0.000163	0.000499	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000163	0.000498	CcSEcCtD
Zonisamide—Dizziness—Prednisolone—multiple sclerosis	0.000162	0.000498	CcSEcCtD
Zonisamide—Asthenia—Triamcinolone—multiple sclerosis	0.000162	0.000497	CcSEcCtD
Zonisamide—Abdominal pain—Betamethasone—multiple sclerosis	0.000162	0.000497	CcSEcCtD
Zonisamide—Body temperature increased—Betamethasone—multiple sclerosis	0.000162	0.000497	CcSEcCtD
Zonisamide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000162	0.000497	CcSEcCtD
Zonisamide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000162	0.000497	CcSEcCtD
Zonisamide—Asthenia—Methylprednisolone—multiple sclerosis	0.000162	0.000496	CcSEcCtD
Zonisamide—Insomnia—Prednisone—multiple sclerosis	0.000161	0.000495	CcSEcCtD
Zonisamide—Paraesthesia—Prednisone—multiple sclerosis	0.00016	0.000491	CcSEcCtD
Zonisamide—Pruritus—Triamcinolone—multiple sclerosis	0.00016	0.00049	CcSEcCtD
Zonisamide—Cough—Methotrexate—multiple sclerosis	0.000159	0.000489	CcSEcCtD
Zonisamide—Pruritus—Methylprednisolone—multiple sclerosis	0.000159	0.000489	CcSEcCtD
Zonisamide—Convulsion—Methotrexate—multiple sclerosis	0.000158	0.000485	CcSEcCtD
Zonisamide—Dyspepsia—Prednisone—multiple sclerosis	0.000157	0.000482	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—multiple sclerosis	0.000156	0.000477	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—multiple sclerosis	0.000156	0.000477	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—multiple sclerosis	0.000156	0.000477	CcSEcCtD
Zonisamide—Decreased appetite—Prednisone—multiple sclerosis	0.000155	0.000476	CcSEcCtD
Zonisamide—Rash—Prednisolone—multiple sclerosis	0.000155	0.000475	CcSEcCtD
Zonisamide—Dermatitis—Prednisolone—multiple sclerosis	0.000155	0.000474	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000155	0.000474	CcSEcCtD
Zonisamide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000154	0.000473	CcSEcCtD
Zonisamide—Fatigue—Prednisone—multiple sclerosis	0.000154	0.000472	CcSEcCtD
Zonisamide—Headache—Prednisolone—multiple sclerosis	0.000154	0.000472	CcSEcCtD
Zonisamide—Discomfort—Methotrexate—multiple sclerosis	0.000154	0.000471	CcSEcCtD
Zonisamide—Constipation—Prednisone—multiple sclerosis	0.000153	0.000468	CcSEcCtD
Zonisamide—Confusional state—Methotrexate—multiple sclerosis	0.00015	0.000461	CcSEcCtD
Zonisamide—Dizziness—Triamcinolone—multiple sclerosis	0.000149	0.000458	CcSEcCtD
Zonisamide—Dizziness—Methylprednisolone—multiple sclerosis	0.000149	0.000457	CcSEcCtD
Zonisamide—Infection—Methotrexate—multiple sclerosis	0.000148	0.000454	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisone—multiple sclerosis	0.000147	0.000451	CcSEcCtD
Zonisamide—Asthenia—Dexamethasone—multiple sclerosis	0.000147	0.000451	CcSEcCtD
Zonisamide—Asthenia—Betamethasone—multiple sclerosis	0.000147	0.000451	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000146	0.000448	CcSEcCtD
Zonisamide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000146	0.000448	CcSEcCtD
Zonisamide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000146	0.000447	CcSEcCtD
Zonisamide—Nausea—Prednisolone—multiple sclerosis	0.000146	0.000447	CcSEcCtD
Zonisamide—Pruritus—Betamethasone—multiple sclerosis	0.000145	0.000444	CcSEcCtD
Zonisamide—Pruritus—Dexamethasone—multiple sclerosis	0.000145	0.000444	CcSEcCtD
Zonisamide—Skin disorder—Methotrexate—multiple sclerosis	0.000145	0.000444	CcSEcCtD
Zonisamide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000144	0.000442	CcSEcCtD
Zonisamide—Vomiting—Triamcinolone—multiple sclerosis	0.000144	0.00044	CcSEcCtD
Zonisamide—Vomiting—Methylprednisolone—multiple sclerosis	0.000143	0.000439	CcSEcCtD
Zonisamide—Rash—Triamcinolone—multiple sclerosis	0.000142	0.000436	CcSEcCtD
Zonisamide—Dermatitis—Triamcinolone—multiple sclerosis	0.000142	0.000436	CcSEcCtD
Zonisamide—Anorexia—Methotrexate—multiple sclerosis	0.000142	0.000436	CcSEcCtD
Zonisamide—Rash—Methylprednisolone—multiple sclerosis	0.000142	0.000436	CcSEcCtD
Zonisamide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000142	0.000435	CcSEcCtD
Zonisamide—Urticaria—Prednisone—multiple sclerosis	0.000142	0.000435	CcSEcCtD
Zonisamide—Headache—Triamcinolone—multiple sclerosis	0.000141	0.000434	CcSEcCtD
Zonisamide—Headache—Methylprednisolone—multiple sclerosis	0.000141	0.000433	CcSEcCtD
Zonisamide—Abdominal pain—Prednisone—multiple sclerosis	0.000141	0.000432	CcSEcCtD
Zonisamide—Body temperature increased—Prednisone—multiple sclerosis	0.000141	0.000432	CcSEcCtD
Zonisamide—Diarrhoea—Dexamethasone—multiple sclerosis	0.00014	0.00043	CcSEcCtD
Zonisamide—Diarrhoea—Betamethasone—multiple sclerosis	0.00014	0.00043	CcSEcCtD
Zonisamide—Hypotension—Methotrexate—multiple sclerosis	0.000139	0.000427	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000136	0.000417	CcSEcCtD
Zonisamide—Dizziness—Dexamethasone—multiple sclerosis	0.000136	0.000415	CcSEcCtD
Zonisamide—Dizziness—Betamethasone—multiple sclerosis	0.000136	0.000415	CcSEcCtD
Zonisamide—Insomnia—Methotrexate—multiple sclerosis	0.000135	0.000413	CcSEcCtD
Zonisamide—Nausea—Triamcinolone—multiple sclerosis	0.000134	0.000411	CcSEcCtD
Zonisamide—Paraesthesia—Methotrexate—multiple sclerosis	0.000134	0.000411	CcSEcCtD
Zonisamide—Nausea—Methylprednisolone—multiple sclerosis	0.000134	0.00041	CcSEcCtD
Zonisamide—Dyspnoea—Methotrexate—multiple sclerosis	0.000133	0.000408	CcSEcCtD
Zonisamide—Somnolence—Methotrexate—multiple sclerosis	0.000133	0.000406	CcSEcCtD
Zonisamide—Hypersensitivity—Prednisone—multiple sclerosis	0.000131	0.000403	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—multiple sclerosis	0.000131	0.000402	CcSEcCtD
Zonisamide—Vomiting—Betamethasone—multiple sclerosis	0.00013	0.000399	CcSEcCtD
Zonisamide—Vomiting—Dexamethasone—multiple sclerosis	0.00013	0.000399	CcSEcCtD
Zonisamide—Decreased appetite—Methotrexate—multiple sclerosis	0.00013	0.000397	CcSEcCtD
Zonisamide—Rash—Dexamethasone—multiple sclerosis	0.000129	0.000396	CcSEcCtD
Zonisamide—Rash—Betamethasone—multiple sclerosis	0.000129	0.000396	CcSEcCtD
Zonisamide—Dermatitis—Dexamethasone—multiple sclerosis	0.000129	0.000396	CcSEcCtD
Zonisamide—Dermatitis—Betamethasone—multiple sclerosis	0.000129	0.000396	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000129	0.000395	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—multiple sclerosis	0.000129	0.000394	CcSEcCtD
Zonisamide—Headache—Betamethasone—multiple sclerosis	0.000128	0.000394	CcSEcCtD
Zonisamide—Headache—Dexamethasone—multiple sclerosis	0.000128	0.000394	CcSEcCtD
Zonisamide—Asthenia—Prednisone—multiple sclerosis	0.000128	0.000392	CcSEcCtD
Zonisamide—Pruritus—Prednisone—multiple sclerosis	0.000126	0.000387	CcSEcCtD
Zonisamide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000123	0.000377	CcSEcCtD
Zonisamide—Diarrhoea—Prednisone—multiple sclerosis	0.000122	0.000374	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000122	0.000374	CcSEcCtD
Zonisamide—Nausea—Betamethasone—multiple sclerosis	0.000122	0.000373	CcSEcCtD
Zonisamide—Nausea—Dexamethasone—multiple sclerosis	0.000122	0.000373	CcSEcCtD
Zonisamide—Urticaria—Methotrexate—multiple sclerosis	0.000118	0.000363	CcSEcCtD
Zonisamide—Dizziness—Prednisone—multiple sclerosis	0.000118	0.000362	CcSEcCtD
Zonisamide—Abdominal pain—Methotrexate—multiple sclerosis	0.000118	0.000361	CcSEcCtD
Zonisamide—Body temperature increased—Methotrexate—multiple sclerosis	0.000118	0.000361	CcSEcCtD
Zonisamide—Vomiting—Prednisone—multiple sclerosis	0.000113	0.000348	CcSEcCtD
Zonisamide—Rash—Prednisone—multiple sclerosis	0.000113	0.000345	CcSEcCtD
Zonisamide—Dermatitis—Prednisone—multiple sclerosis	0.000112	0.000345	CcSEcCtD
Zonisamide—Headache—Prednisone—multiple sclerosis	0.000112	0.000343	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—MMP9—multiple sclerosis	0.000111	0.000587	CbGpPWpGaD
Zonisamide—Hypersensitivity—Methotrexate—multiple sclerosis	0.00011	0.000337	CcSEcCtD
Zonisamide—CA1—Metabolism—GPC5—multiple sclerosis	0.00011	0.000582	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—BCHE—multiple sclerosis	0.000108	0.000572	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GPC5—multiple sclerosis	0.000108	0.000571	CbGpPWpGaD
Zonisamide—Asthenia—Methotrexate—multiple sclerosis	0.000107	0.000328	CcSEcCtD
Zonisamide—SCN2B—Developmental Biology—IL6—multiple sclerosis	0.000107	0.000567	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—IL6—multiple sclerosis	0.000107	0.000567	CbGpPWpGaD
Zonisamide—Nausea—Prednisone—multiple sclerosis	0.000106	0.000325	CcSEcCtD
Zonisamide—CA9—Metabolism—CYP27B1—multiple sclerosis	0.000106	0.000559	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP24A1—multiple sclerosis	0.000106	0.000559	CbGpPWpGaD
Zonisamide—Pruritus—Methotrexate—multiple sclerosis	0.000106	0.000323	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—MMP9—multiple sclerosis	0.000105	0.000556	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000104	0.00055	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000104	0.00055	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—TYK2—multiple sclerosis	0.000104	0.000549	CbGpPWpGaD
Zonisamide—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000104	0.000548	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000103	0.000543	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000103	0.000543	CbGpPWpGaD
Zonisamide—Diarrhoea—Methotrexate—multiple sclerosis	0.000102	0.000313	CcSEcCtD
Zonisamide—CACNA1H—Axon guidance—TYK2—multiple sclerosis	0.0001	0.000532	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TYK2—multiple sclerosis	0.0001	0.000532	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP27B1—multiple sclerosis	9.95e-05	0.000527	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP24A1—multiple sclerosis	9.95e-05	0.000527	CbGpPWpGaD
Zonisamide—CA4—Metabolism—RRM1—multiple sclerosis	9.9e-05	0.000524	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—TYK2—multiple sclerosis	9.87e-05	0.000523	CbGpPWpGaD
Zonisamide—Dizziness—Methotrexate—multiple sclerosis	9.86e-05	0.000302	CcSEcCtD
Zonisamide—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	9.8e-05	0.000519	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—IL6—multiple sclerosis	9.78e-05	0.000518	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GPC5—multiple sclerosis	9.66e-05	0.000511	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TYK2—multiple sclerosis	9.52e-05	0.000504	CbGpPWpGaD
Zonisamide—CA2—Metabolism—RRM1—multiple sclerosis	9.49e-05	0.000503	CbGpPWpGaD
Zonisamide—Vomiting—Methotrexate—multiple sclerosis	9.48e-05	0.000291	CcSEcCtD
Zonisamide—SCN3A—Axon guidance—TYK2—multiple sclerosis	9.44e-05	0.0005	CbGpPWpGaD
Zonisamide—Rash—Methotrexate—multiple sclerosis	9.4e-05	0.000288	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—multiple sclerosis	9.39e-05	0.000288	CcSEcCtD
Zonisamide—Headache—Methotrexate—multiple sclerosis	9.34e-05	0.000286	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	9.21e-05	0.000488	CbGpPWpGaD
Zonisamide—CA1—Metabolism—RRM1—multiple sclerosis	9.1e-05	0.000482	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GPC5—multiple sclerosis	9.1e-05	0.000482	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—IL6—multiple sclerosis	9.1e-05	0.000482	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—TYK2—multiple sclerosis	9.07e-05	0.00048	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—TYK2—multiple sclerosis	9.07e-05	0.00048	CbGpPWpGaD
Zonisamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.03e-05	0.000478	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—MAPK1—multiple sclerosis	8.96e-05	0.000474	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—RRM1—multiple sclerosis	8.93e-05	0.000473	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SRM—multiple sclerosis	8.86e-05	0.000469	CbGpPWpGaD
Zonisamide—Nausea—Methotrexate—multiple sclerosis	8.86e-05	0.000272	CcSEcCtD
Zonisamide—SCN1A—Axon guidance—TYK2—multiple sclerosis	8.74e-05	0.000463	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—MAPK1—multiple sclerosis	8.49e-05	0.00045	CbGpPWpGaD
Zonisamide—CA14—Metabolism—BCHE—multiple sclerosis	8.46e-05	0.000448	CbGpPWpGaD
Zonisamide—AOX1—Disease—RPL5—multiple sclerosis	8.36e-05	0.000443	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—BCHE—multiple sclerosis	8.25e-05	0.000437	CbGpPWpGaD
Zonisamide—CA6—Metabolism—BCHE—multiple sclerosis	8.25e-05	0.000437	CbGpPWpGaD
Zonisamide—MAOA—Biological oxidations—POMC—multiple sclerosis	8.21e-05	0.000435	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—MMP9—multiple sclerosis	8.17e-05	0.000433	CbGpPWpGaD
Zonisamide—AOX1—Disease—SLC11A1—multiple sclerosis	8.01e-05	0.000424	CbGpPWpGaD
Zonisamide—CA9—Metabolism—RRM1—multiple sclerosis	8e-05	0.000424	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—MMP9—multiple sclerosis	7.91e-05	0.000419	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MMP9—multiple sclerosis	7.91e-05	0.000419	CbGpPWpGaD
Zonisamide—CA3—Metabolism—APOE—multiple sclerosis	7.9e-05	0.000418	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—MMP9—multiple sclerosis	7.77e-05	0.000412	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—BCHE—multiple sclerosis	7.7e-05	0.000408	CbGpPWpGaD
Zonisamide—CA7—Metabolism—BCHE—multiple sclerosis	7.7e-05	0.000408	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—RRM1—multiple sclerosis	7.54e-05	0.000399	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MMP9—multiple sclerosis	7.5e-05	0.000397	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—MMP9—multiple sclerosis	7.43e-05	0.000394	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TYK2—multiple sclerosis	7.4e-05	0.000392	CbGpPWpGaD
Zonisamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.32e-05	0.000388	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TYK2—multiple sclerosis	7.17e-05	0.00038	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—MMP9—multiple sclerosis	7.14e-05	0.000378	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MMP9—multiple sclerosis	7.14e-05	0.000378	CbGpPWpGaD
Zonisamide—CA12—Metabolism—BCHE—multiple sclerosis	7.13e-05	0.000378	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TYK2—multiple sclerosis	7.04e-05	0.000373	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—STAT3—multiple sclerosis	7.03e-05	0.000372	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MMP9—multiple sclerosis	6.89e-05	0.000365	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—IL6—multiple sclerosis	6.88e-05	0.000365	CbGpPWpGaD
Zonisamide—CA3—Metabolism—POMC—multiple sclerosis	6.79e-05	0.000359	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TYK2—multiple sclerosis	6.74e-05	0.000357	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.69e-05	0.000354	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—STAT3—multiple sclerosis	6.67e-05	0.000353	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.64e-05	0.000352	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.64e-05	0.000352	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—MAPK1—multiple sclerosis	6.6e-05	0.00035	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.59e-05	0.000349	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—IL6—multiple sclerosis	6.52e-05	0.000346	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TGFB1—multiple sclerosis	6.52e-05	0.000345	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TYK2—multiple sclerosis	6.47e-05	0.000343	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TYK2—multiple sclerosis	6.47e-05	0.000343	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD28—multiple sclerosis	6.4e-05	0.000339	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—MAPK1—multiple sclerosis	6.4e-05	0.000339	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MAPK1—multiple sclerosis	6.39e-05	0.000339	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—MAPK1—multiple sclerosis	6.28e-05	0.000333	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP27B1—multiple sclerosis	6.24e-05	0.000331	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP24A1—multiple sclerosis	6.24e-05	0.000331	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TYK2—multiple sclerosis	6.24e-05	0.00033	CbGpPWpGaD
Zonisamide—CA3—Metabolism—ALB—multiple sclerosis	6.19e-05	0.000328	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TGFB1—multiple sclerosis	6.18e-05	0.000327	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—TYK2—multiple sclerosis	6.15e-05	0.000326	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—STAT3—multiple sclerosis	6.13e-05	0.000325	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TNF—multiple sclerosis	6.09e-05	0.000322	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MAPK1—multiple sclerosis	6.06e-05	0.000321	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—MAPK1—multiple sclerosis	6.01e-05	0.000318	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MMP9—multiple sclerosis	5.83e-05	0.000309	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—MAPK1—multiple sclerosis	5.77e-05	0.000306	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MAPK1—multiple sclerosis	5.77e-05	0.000306	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TNF—multiple sclerosis	5.77e-05	0.000306	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GPC5—multiple sclerosis	5.71e-05	0.000302	CbGpPWpGaD
Zonisamide—CA4—Metabolism—BCHE—multiple sclerosis	5.69e-05	0.000301	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MMP9—multiple sclerosis	5.65e-05	0.000299	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—MAPK1—multiple sclerosis	5.58e-05	0.000295	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MAPK1—multiple sclerosis	5.57e-05	0.000295	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MMP9—multiple sclerosis	5.55e-05	0.000294	CbGpPWpGaD
Zonisamide—CA2—Metabolism—BCHE—multiple sclerosis	5.45e-05	0.000289	CbGpPWpGaD
Zonisamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.43e-05	0.000288	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.4e-05	0.000286	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MMP9—multiple sclerosis	5.3e-05	0.000281	CbGpPWpGaD
Zonisamide—CA1—Metabolism—BCHE—multiple sclerosis	5.23e-05	0.000277	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—STAT3—multiple sclerosis	5.18e-05	0.000275	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—BCHE—multiple sclerosis	5.13e-05	0.000272	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MMP9—multiple sclerosis	5.1e-05	0.00027	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MMP9—multiple sclerosis	5.1e-05	0.00027	CbGpPWpGaD
Zonisamide—CA14—Metabolism—APOE—multiple sclerosis	5.09e-05	0.00027	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—IL6—multiple sclerosis	5.07e-05	0.000269	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—STAT3—multiple sclerosis	5.02e-05	0.000266	CbGpPWpGaD
Zonisamide—CA6—Metabolism—APOE—multiple sclerosis	4.96e-05	0.000263	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—APOE—multiple sclerosis	4.96e-05	0.000263	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—STAT3—multiple sclerosis	4.93e-05	0.000261	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—IL6—multiple sclerosis	4.91e-05	0.00026	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MMP9—multiple sclerosis	4.91e-05	0.00026	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—IL6—multiple sclerosis	4.91e-05	0.00026	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MMP9—multiple sclerosis	4.84e-05	0.000256	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—IL6—multiple sclerosis	4.83e-05	0.000256	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TGFB1—multiple sclerosis	4.81e-05	0.000254	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.78e-05	0.000253	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—RRM1—multiple sclerosis	4.73e-05	0.000251	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—STAT3—multiple sclerosis	4.72e-05	0.00025	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MAPK1—multiple sclerosis	4.71e-05	0.00025	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—IL6—multiple sclerosis	4.66e-05	0.000247	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TGFB1—multiple sclerosis	4.65e-05	0.000246	CbGpPWpGaD
Zonisamide—CA7—Metabolism—APOE—multiple sclerosis	4.63e-05	0.000245	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—APOE—multiple sclerosis	4.63e-05	0.000245	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—IL6—multiple sclerosis	4.62e-05	0.000244	CbGpPWpGaD
Zonisamide—CA9—Metabolism—BCHE—multiple sclerosis	4.6e-05	0.000243	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	4.57e-05	0.000242	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD86—multiple sclerosis	4.56e-05	0.000242	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MAPK1—multiple sclerosis	4.56e-05	0.000242	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—STAT3—multiple sclerosis	4.53e-05	0.00024	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—STAT3—multiple sclerosis	4.53e-05	0.00024	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TNF—multiple sclerosis	4.49e-05	0.000238	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	4.48e-05	0.000237	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—IL6—multiple sclerosis	4.44e-05	0.000235	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—IL6—multiple sclerosis	4.44e-05	0.000235	CbGpPWpGaD
Zonisamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.4e-05	0.000233	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TYK2—multiple sclerosis	4.39e-05	0.000232	CbGpPWpGaD
Zonisamide—CA14—Metabolism—POMC—multiple sclerosis	4.37e-05	0.000232	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TGFB1—multiple sclerosis	4.37e-05	0.000232	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—STAT3—multiple sclerosis	4.37e-05	0.000231	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TNF—multiple sclerosis	4.35e-05	0.00023	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—BCHE—multiple sclerosis	4.33e-05	0.000229	CbGpPWpGaD
Zonisamide—CA12—Metabolism—APOE—multiple sclerosis	4.29e-05	0.000227	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MAPK1—multiple sclerosis	4.29e-05	0.000227	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—IL6—multiple sclerosis	4.28e-05	0.000227	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—IL6—multiple sclerosis	4.28e-05	0.000226	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TNF—multiple sclerosis	4.27e-05	0.000226	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—POMC—multiple sclerosis	4.26e-05	0.000226	CbGpPWpGaD
Zonisamide—CA6—Metabolism—POMC—multiple sclerosis	4.26e-05	0.000226	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	4.2e-05	0.000222	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TGFB1—multiple sclerosis	4.2e-05	0.000222	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SRM—multiple sclerosis	4.2e-05	0.000222	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	4.12e-05	0.000218	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MAPK1—multiple sclerosis	4.12e-05	0.000218	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.12e-05	0.000218	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—multiple sclerosis	4.08e-05	0.000216	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	4.05e-05	0.000214	CbGpPWpGaD
Zonisamide—AOX1—Disease—CCR5—multiple sclerosis	4.05e-05	0.000214	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ALB—multiple sclerosis	3.99e-05	0.000211	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—POMC—multiple sclerosis	3.98e-05	0.000211	CbGpPWpGaD
Zonisamide—CA7—Metabolism—POMC—multiple sclerosis	3.98e-05	0.000211	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	3.97e-05	0.00021	CbGpPWpGaD
Zonisamide—AOX1—Disease—HLA-A—multiple sclerosis	3.94e-05	0.000209	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—multiple sclerosis	3.92e-05	0.000208	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—multiple sclerosis	3.92e-05	0.000208	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MAPK1—multiple sclerosis	3.91e-05	0.000207	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.89e-05	0.000206	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—ALB—multiple sclerosis	3.89e-05	0.000206	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ALB—multiple sclerosis	3.89e-05	0.000206	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.86e-05	0.000204	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—multiple sclerosis	3.78e-05	0.0002	CbGpPWpGaD
Zonisamide—CA12—Metabolism—POMC—multiple sclerosis	3.69e-05	0.000195	CbGpPWpGaD
Zonisamide—AOX1—Disease—APOE—multiple sclerosis	3.68e-05	0.000195	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ALB—multiple sclerosis	3.63e-05	0.000192	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ALB—multiple sclerosis	3.63e-05	0.000192	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—IL6—multiple sclerosis	3.62e-05	0.000192	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—IL6—multiple sclerosis	3.51e-05	0.000186	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP9—multiple sclerosis	3.45e-05	0.000183	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—IL6—multiple sclerosis	3.44e-05	0.000182	CbGpPWpGaD
Zonisamide—CA4—Metabolism—APOE—multiple sclerosis	3.42e-05	0.000181	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ALB—multiple sclerosis	3.36e-05	0.000178	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD80—multiple sclerosis	3.33e-05	0.000176	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—IL6—multiple sclerosis	3.29e-05	0.000174	CbGpPWpGaD
Zonisamide—CA2—Metabolism—APOE—multiple sclerosis	3.28e-05	0.000174	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—IL6—multiple sclerosis	3.17e-05	0.000168	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—IL6—multiple sclerosis	3.17e-05	0.000168	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—MAPK1—multiple sclerosis	3.15e-05	0.000167	CbGpPWpGaD
Zonisamide—CA1—Metabolism—APOE—multiple sclerosis	3.15e-05	0.000167	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—APOE—multiple sclerosis	3.08e-05	0.000163	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—STAT3—multiple sclerosis	3.07e-05	0.000163	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—IL6—multiple sclerosis	3.05e-05	0.000162	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—IL6—multiple sclerosis	3.01e-05	0.000159	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.96e-05	0.000157	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.96e-05	0.000157	CbGpPWpGaD
Zonisamide—CA4—Metabolism—POMC—multiple sclerosis	2.94e-05	0.000156	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.89e-05	0.000153	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	2.85e-05	0.000151	CbGpPWpGaD
Zonisamide—CA2—Metabolism—POMC—multiple sclerosis	2.82e-05	0.000149	CbGpPWpGaD
Zonisamide—AOX1—Disease—TYK2—multiple sclerosis	2.81e-05	0.000149	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	2.79e-05	0.000148	CbGpPWpGaD
Zonisamide—CA9—Metabolism—APOE—multiple sclerosis	2.76e-05	0.000146	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—BCHE—multiple sclerosis	2.72e-05	0.000144	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.7e-05	0.000143	CbGpPWpGaD
Zonisamide—CA1—Metabolism—POMC—multiple sclerosis	2.7e-05	0.000143	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ALB—multiple sclerosis	2.68e-05	0.000142	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—multiple sclerosis	2.66e-05	0.000141	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—POMC—multiple sclerosis	2.65e-05	0.00014	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—APOE—multiple sclerosis	2.61e-05	0.000138	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ALB—multiple sclerosis	2.57e-05	0.000136	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD4—multiple sclerosis	2.54e-05	0.000135	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SRM—multiple sclerosis	2.52e-05	0.000134	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ALB—multiple sclerosis	2.46e-05	0.00013	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ALB—multiple sclerosis	2.42e-05	0.000128	CbGpPWpGaD
Zonisamide—CA9—Metabolism—POMC—multiple sclerosis	2.38e-05	0.000126	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.34e-05	0.000124	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.24e-05	0.000119	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—POMC—multiple sclerosis	2.24e-05	0.000119	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ALB—multiple sclerosis	2.17e-05	0.000115	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—multiple sclerosis	2.15e-05	0.000114	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ALB—multiple sclerosis	2.04e-05	0.000108	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—multiple sclerosis	1.97e-05	0.000104	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—multiple sclerosis	1.83e-05	9.69e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFB1—multiple sclerosis	1.82e-05	9.66e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK1—multiple sclerosis	1.79e-05	9.48e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.78e-05	9.41e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.78e-05	9.41e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.74e-05	9.2e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—APOE—multiple sclerosis	1.64e-05	8.66e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.63e-05	8.61e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.49e-05	7.91e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—POMC—multiple sclerosis	1.4e-05	7.44e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—multiple sclerosis	1.37e-05	7.28e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.36e-05	7.21e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.35e-05	7.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.29e-05	6.81e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALB—multiple sclerosis	1.28e-05	6.78e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APOE—multiple sclerosis	7.74e-06	4.1e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.74e-06	4.1e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—POMC—multiple sclerosis	6.65e-06	3.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALB—multiple sclerosis	6.06e-06	3.21e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APOE—multiple sclerosis	4.65e-06	2.47e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—POMC—multiple sclerosis	4e-06	2.12e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALB—multiple sclerosis	3.65e-06	1.93e-05	CbGpPWpGaD
